VEGFA and macular retinal edema: The main outcome measure was absence of visual acuity (VA) improvement due to macular oedema failure of anti-VEGF therapy (defined as VA gain <5 ETDRS letters and CST increase of 50 μm or CST > 325 μm) modelled using time-event analyzes of appropriately loaded patients.